Suzuki, R., Amatya, V. J., Kushitani, K., Kai, Y., Kambara, T., Fujii, Y., & Takeshima, Y. (2020). Inhibition of miR-18a-3p reduces proliferation of mesothelioma cells and sensitizes them to cisplatin. Oncol Lett.

Suzuki, Rui, Vishwa Jeet Amatya, Kei Kushitani, Yuichiro Kai, Takahiro Kambara, Yutaro Fujii, and Yukio Takeshima. "Inhibition of MiR-18a-3p Reduces Proliferation of Mesothelioma Cells and Sensitizes Them to Cisplatin." Oncol Lett 2020.

Suzuki, Rui, et al. "Inhibition of MiR-18a-3p Reduces Proliferation of Mesothelioma Cells and Sensitizes Them to Cisplatin." Oncol Lett 2020.